Why the study?
Does admission blood glucose or a previous diagnosis of diabetes mellitus independently predict 30-day mortality in STEMI patients undergoing primary PCI?
Population
740 ST segment elevation myocardial infarction patients submitted to primary coronary percutaneous…
Design
Cohort
Follow-up
30 days
Authors
Loading...
May refine 30-day risk stratification in STEMI PCI beyond diabetes history; hypothesis-generating and should not yet change practice.
Does admission blood glucose or a previous diagnosis of diabetes mellitus independently predict 30-day mortality in STEMI patients undergoing primary PCI?
In STEMI patients undergoing primary PCI, admission blood glucose is a more accurate and robust independent predictor of 30-day mortality than a prior diagnosis of diabetes.
David et al. (2014) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: